A sandwich enzyme-linked immunosorbent assay for beta 2-glycoprotein I

P A Sansom1, C T Marlow, M Lapsley

  • 1Department of Chemical Pathology, University College and Middlesex School of Medicine, London, UK.

Insights

A new enzyme-linked immunosorbent assay accurately measures beta 2-glycoprotein I in urine and serum. This method offers a reliable detection range and low variability for clinical diagnostics.

Area of Science:

  • Biochemistry
  • Immunology
  • Clinical Chemistry

Background:

  • Beta 2-glycoprotein I (Apolipoprotein H) is a plasma protein with implications in thrombosis and autoimmune diseases.
  • Accurate quantification of beta 2-glycoprotein I is crucial for diagnosing and monitoring certain medical conditions.

Purpose of the Study:

  • To develop and validate a sensitive solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) for quantifying beta 2-glycoprotein I.
  • To assess the assay's performance characteristics in urine samples and its applicability to serum.

Main Methods:

  • Development of a solid-phase sandwich ELISA.
  • Characterization of assay parameters including working range, detection limit, and precision (within-plate and between-batch CV).
  • Evaluation of analyte recovery in spiked urine samples.

Main Results:

  • The developed ELISA demonstrates a working concentration range of 5-40 µg/L and a detection limit of approximately 1.4 µg/L.
  • High precision was observed with within-plate CVs of 1.4-2.1% and between-batch CVs of 5.2-6.0%.
  • Excellent recovery rates (96-110%) indicate assay accuracy for beta 2-glycoprotein I in urine.

Conclusions:

  • A robust and sensitive ELISA for beta 2-glycoprotein I determination in urine has been successfully developed.
  • The assay exhibits favorable precision and accuracy, making it suitable for clinical applications.
  • The method's adaptability for serum analysis broadens its diagnostic potential.